UK biotech firms eye Nasdaq listings
Immunocore, the UK biotech company, has filed for an IPO on the Nasdaq in New York following a $75m series ‘C’ funding round which concluded last week.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: